In reality, program design covers everything from offer amount and caps to eligibility rules and channel mix, yet many ...
Within the context of “The Great Repricing,” this distinction matters. The pressure on the commercial channel is not coming ...
In today’s Pharma Pulse, the FTC secures a multi-billion-dollar settlement against the "rebate trap," while Congress provides ...
Since TrumpRx was announced in 2025, 16 Big Pharma companies have agreed to sell their drugs via the platform, including ...
What 2025 means for the life sciences sector in the New Year. If I had to describe 2025 in one phrase, it would be this: a year of two halves, held together by uncertainty.
1. FTC Secures Landmark Settlement with Express Scripts to Lower Drug Costs for American Patients. United States Federal ...
In today’s Pharma Pulse, the biopharma landscape enters a transformative phase as the US signs landmark PBM reforms into law, ...
In today’s Pharma Pulse, AstraZeneca faces a complete response letter for its self-injectable lupus drug, while the EMA gives ...
Roth began by sharing what he believes to be the single-most important characteristic of pharma company long-term survival ...
Hudicka also comments on practical steps can supply chain leaders take to build trust in AI-driven ecosystems without ...
In the first part of his Pharma Commerce video interview, Joe Hudicka, entrepreneur and supply chain expert, explains how ...
Körber, a provider of manufacturing and supply chain solutions—including for the pharma industry—has struck a deal to acquire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results